David McIntosh Shares: Egypt Achieves Self-Sufficiency in Plasma-Derived Medicines Thanks to Grifols
David McIntosh, Founder and Chair of United Plasma Action, posted on LinkedIn:
“Excellent News for Egyptian Patients AND a guiding light for other nations!!
I feel sure that fellow LinkedIners with a keen interest in blood, plasma and derived life-saving medicines will have found this news as exciting as Egyptian patients did:
Read the paper here.
While the fully appropriate treatment of all patients and currently undiagnosed sufferers, across all Low and Middle Income Countries, is still a long way off, progress in Egypt must surely give hope to millions way beyond that country’s borders.
The speed of progress has been immensely impressive, immediately starting to save lives after years of unsuccessful struggling against chronic national shortages of vital plasma-derived medicines.
The key ingredients?? –
a) The successful implementation of a positive public/private partnership
and
b) The introduction of plasmapheresis collection using the time-honoured method of Voluntary Reasonably Compensated Donation (VRCD)
Thus Egypt joins Germany, Austria, Hungary and Czechia in successfully adopting the American approach to plasma collection that has served those countries so well for so many years.
A hearty cheer for patient-centred, caring, common sense!!!
Hopefully, the backwoodsmen in Europe will finally sit up and take notice. Those who still advocate for uncompensated plasma donation and allow themselves to stay reliant on US imports to treat their patients properly must surely wake up to reality some time soon ….”
Read more from David McIntosh on Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow